ArticleIn vivo (Athens, Greece)

Onset and Outcomes of Immune-related Adverse Events in Genitourinary Cancer Treated With Immune Checkpoint Inhibitors.

Minoru Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.